Free Trial

Dynatronics (DYNT) Competitors

Dynatronics logo
$0.12 -0.01 (-3.85%)
As of 02/21/2025 02:27 PM Eastern

DYNT vs. SINT, HSCS, AMIX, NDRA, GMVDF, BBLG, VERO, HSDT, BJDX, and STSS

Should you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include Sintx Technologies (SINT), Heart Test Laboratories (HSCS), Autonomix Medical (AMIX), ENDRA Life Sciences (NDRA), G Medical Innovations (GMVDF), Bone Biologics (BBLG), Venus Concept (VERO), Helius Medical Technologies (HSDT), Bluejay Diagnostics (BJDX), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.

Dynatronics vs.

Dynatronics (NASDAQ:DYNT) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

Dynatronics has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500.

Dynatronics received 273 more outperform votes than Sintx Technologies when rated by MarketBeat users. However, 61.02% of users gave Sintx Technologies an outperform vote while only 47.91% of users gave Dynatronics an outperform vote.

CompanyUnderperformOutperform
DynatronicsOutperform Votes
309
47.91%
Underperform Votes
336
52.09%
Sintx TechnologiesOutperform Votes
36
61.02%
Underperform Votes
23
38.98%

In the previous week, Sintx Technologies had 8 more articles in the media than Dynatronics. MarketBeat recorded 9 mentions for Sintx Technologies and 1 mentions for Dynatronics. Sintx Technologies' average media sentiment score of 0.21 beat Dynatronics' score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Dynatronics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sintx Technologies
1 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

4.2% of Dynatronics shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 8.0% of Dynatronics shares are held by insiders. Comparatively, 0.0% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Dynatronics has a net margin of -8.35% compared to Sintx Technologies' net margin of -358.79%. Dynatronics' return on equity of -41.81% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Dynatronics-8.35% -41.81% -9.56%
Sintx Technologies -358.79%-140.68%-78.29%

Dynatronics has higher revenue and earnings than Sintx Technologies. Dynatronics is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dynatronics$32.53M0.03-$2.70M-$0.82-0.15
Sintx Technologies$2.63M2.71-$8.26M-$50.56-0.11

Summary

Dynatronics beats Sintx Technologies on 8 of the 15 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DYNT vs. The Competition

MetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.15M$4.74B$5.84B$9.15B
Dividend YieldN/A39.90%4.75%3.85%
P/E Ratio-0.1528.5326.1519.13
Price / Sales0.0353.64435.3370.72
Price / CashN/A51.1038.0134.83
Price / Book0.226.577.644.62
Net Income-$2.70M$90.91M$3.19B$245.94M
7 Day Performance-0.79%-2.39%-2.11%-2.62%
1 Month Performance-8.76%-2.29%-0.49%-2.15%
1 Year Performance-75.00%15.21%16.44%12.95%

Dynatronics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DYNT
Dynatronics
N/A$0.13
-3.8%
N/A-74.0%$1.15M$32.53M-0.15200Analyst Forecast
Gap Up
SINT
Sintx Technologies
1.0023 of 5 stars
$2.95
-0.7%
N/A-82.2%$3.95M$2.63M-0.0640News Coverage
HSCS
Heart Test Laboratories
2.4807 of 5 stars
$3.91
+2.6%
$13.50
+245.3%
-69.2%$3.83M$20,000.00-0.4910Positive News
Gap Down
AMIX
Autonomix Medical
1.8583 of 5 stars
$2.84
-0.4%
$28.00
+885.9%
-96.2%$3.27MN/A-0.181News Coverage
NDRA
ENDRA Life Sciences
2.3349 of 5 stars
$5.02
+0.1%
$700,000.00
+13,958,025.6%
-100.0%$2.71MN/A-0.0120Gap Up
GMVDF
G Medical Innovations
N/AN/AN/A-99.3%$2.60M$4.42M0.0072
BBLG
Bone Biologics
0.2306 of 5 stars
$1.04
+1.0%
N/A-67.9%$2.59MN/A0.002
VERO
Venus Concept
N/A$0.33
-1.0%
N/A-74.6%$2.41M$76.35M-0.04410Gap Down
HSDT
Helius Medical Technologies
1.8695 of 5 stars
$0.55
+6.5%
$24.00
+4,287.6%
-90.7%$2.04M$640,000.00-0.0930Positive News
BJDX
Bluejay Diagnostics
N/A$3.55
-5.0%
N/A-98.9%$1.96M$250,000.000.009Negative News
STSS
Sharps Technology
0.294 of 5 stars
$0.35
-4.2%
N/AN/A$1.92MN/A-0.043Negative News

Related Companies and Tools


This page (NASDAQ:DYNT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners